StemCellAdvice OÜ

Active Registry code 17115523 OÜ Alliklepa küla Registered 18 Nov 2024
Compare

StemCellAdvice OÜ is a OÜ based in Alliklepa küla, registry code 17115523, status: active. Main activity: Blood-, sperm and similar banks activities. Its annual report for 2025 shows revenue of €510 and 0 employees.

Revenue
510 €
Employees
0

2025 · annual report, e-Äriregister

Position in the industry Human health activities · EMTAK 86

  • Revenue · 2025 510 €
    industry median 20 811 € · companies in the industry: 3 373

Taxes and turnover

No tax data available. EMTA publishes data for those who paid state taxes, filed a VAT return or had employees in the quarter. New and small companies may be missing.

Financials by year

2025 – 2025
Revenue, € 2025: 510 € · industry median 20 811 € · above 21% of the industry
05 00010 00015 00020 00025 0002025 Company: 510 € Industry median: 20 811 €202505 00010 00015 00020 00025 0002025 Company: 510 € Industry median: 20 811 €2025
  • Company
  • Industry median

Industry: Human health activities (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Net profit, € 2025: 510 € · industry median 1 071 € · above 45% of the industry
02505007501 0001 2502025 Company: 510 € Industry median: 1 071 €202502505007501 0001 2502025 Company: 510 € Industry median: 1 071 €2025
  • Company
  • Industry median

Industry: Human health activities (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Assets, € 2025: 520 €
02004006002025 Company: 520 €202502004006002025 Company: 520 €2025
Equity, € 2025: 520 €
02004006002025 Company: 520 €202502004006002025 Company: 520 €2025
Employees 2025: 0 · industry median 2 · above 2% of the industry
0.00.51.01.52.02025 Company: 0 Industry median: 220250.00.51.01.52.02025 Company: 0 Industry median: 22025
  • Company
  • Industry median

Industry: Human health activities (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Financials by year
Year Revenue, € Net profit, € Labour costs, € Assets, € Equity, € Employees
2025 510 510 0 520 520 0

Figures from the company’s own (non-consolidated) balance sheet and income statement. A loss is shown with a minus sign.

Financial ratios for 2025

Net profit margin
100.0 %
Net profit / revenue
Return on equity (ROE)
98.1 %
Net profit / equity
Return on assets (ROA)
98.1 %
Net profit / assets
Equity ratio
100.0 %
Equity / assets

Annual reports

PDFs from e-Äriregister
Annual reports
Year Period Filed Report Documents
2025 18 Nov 2024 – 31 Dec 2025 14 Apr 2026 Company’s own e-Äriregister

Board

Right of representation

Any member of the management board may represent the private limited company in all transactions.

Owners

Beneficial owners

Founders and other persons

shared board members, owners or beneficial owners

Activities (EMTAK)

  • 86991Blood-, sperm and similar banks activities Main
Rulings
Number, date Title Deadline State Document
Ä 50269118
18 Nov 2024
First entry In force
18 Nov 2024
PDF

Sources: e-Äriregister and EMTA. Data updated 30 Oct 2026. Open at the source ↗ · Report an error in the data